Published in Proc Natl Acad Sci U S A on January 01, 1992
Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest (1995) 5.09
Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin. Proc Natl Acad Sci U S A (1992) 3.72
Plant immunity requires conformational changes [corrected] of NPR1 via S-nitrosylation and thioredoxins. Science (2008) 3.43
Redox-based regulation of signal transduction: principles, pitfalls, and promises. Free Radic Biol Med (2008) 3.38
Glutamate receptors, neurotoxicity and neurodegeneration. Pflugers Arch (2010) 2.83
Genetic and redox determinants of nitric oxide cytotoxicity in a Salmonella typhimurium model. Proc Natl Acad Sci U S A (1995) 2.83
S-nitrosohemoglobin deficiency: a mechanism for loss of physiological activity in banked blood. Proc Natl Acad Sci U S A (2007) 2.77
Suppression of apoptosis by nitric oxide via inhibition of interleukin-1beta-converting enzyme (ICE)-like and cysteine protease protein (CPP)-32-like proteases. J Exp Med (1997) 2.76
Endogenous nitrogen oxides and bronchodilator S-nitrosothiols in human airways. Proc Natl Acad Sci U S A (1993) 2.64
H₂S signalling through protein sulfhydration and beyond. Nat Rev Mol Cell Biol (2012) 2.59
Nitrosative stress linked to sporadic Parkinson's disease: S-nitrosylation of parkin regulates its E3 ubiquitin ligase activity. Proc Natl Acad Sci U S A (2004) 2.55
Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. J Clin Invest (1993) 2.47
S-nitroso-glutathione inhibits platelet activation in vitro and in vivo. Br J Pharmacol (1992) 2.39
Control of cardiac muscle cell function by an endogenous nitric oxide signaling system. Proc Natl Acad Sci U S A (1993) 2.32
Hydrogen sulfide as a gasotransmitter. J Neurochem (2010) 2.30
Redox modulation of L-type calcium channels in ferret ventricular myocytes. Dual mechanism regulation by nitric oxide and S-nitrosothiols. J Gen Physiol (1996) 2.24
S-Nitrosylation of mitochondrial caspases. J Cell Biol (2001) 2.17
Nitric oxide potentiates hydrogen peroxide-induced killing of Escherichia coli. J Exp Med (1995) 2.14
Nitroglycerin and Nitric Oxide--A Rondo of Themes in Cardiovascular Therapeutics. N Engl J Med (2015) 2.12
Erythrocytes are the major intravascular storage sites of nitrite in human blood. Blood (2005) 2.08
Dietary nitrite supplementation protects against myocardial ischemia-reperfusion injury. Proc Natl Acad Sci U S A (2007) 2.02
Nitric oxide regulates endocytosis by S-nitrosylation of dynamin. Proc Natl Acad Sci U S A (2006) 1.99
Nitric oxide synthase generates nitric oxide locally to regulate compartmentalized protein S-nitrosylation and protein trafficking. Proc Natl Acad Sci U S A (2006) 1.97
Selective neuronal vulnerability to oxidative stress in the brain. Front Aging Neurosci (2010) 1.96
The intracellular dynamic of protein palmitoylation. J Cell Biol (2010) 1.95
Role of nitric oxide in parasitic infections. Microbiol Rev (1995) 1.91
Targeted disruption of serine racemase affects glutamatergic neurotransmission and behavior. Mol Psychiatry (2008) 1.88
Biosynthesis of nitric oxide activates iron regulatory factor in macrophages. EMBO J (1993) 1.83
Methods to detect nitric oxide and its metabolites in biological samples. Free Radic Biol Med (2007) 1.81
Nitric oxide negatively regulates c-Jun N-terminal kinase/stress-activated protein kinase by means of S-nitrosylation. Proc Natl Acad Sci U S A (2000) 1.70
Multiple roles of nitric oxide in the airways. Thorax (2003) 1.69
Inhaled NO as a viable antiadhesive therapy for ischemia/reperfusion injury of distal microvascular beds. J Clin Invest (1998) 1.68
Biological activity of nitric oxide in the plasmatic compartment. Proc Natl Acad Sci U S A (2004) 1.68
Red blood cells stored for increasing periods produce progressive impairments in nitric oxide-mediated vasodilation. Transfusion (2013) 1.62
Aberrant protein s-nitrosylation in neurodegenerative diseases. Neuron (2013) 1.55
An autocatalytic mechanism of protein nitrosylation. Proc Natl Acad Sci U S A (2000) 1.54
Neural roles for heme oxygenase: contrasts to nitric oxide synthase. Proc Natl Acad Sci U S A (2001) 1.53
Paradoxical fate and biological action of peroxynitrite on human platelets. Proc Natl Acad Sci U S A (1994) 1.53
In vivo transfer of nitric oxide between a plasma protein-bound reservoir and low molecular weight thiols. J Clin Invest (1994) 1.53
Mechanism of transfer of NO from extracellular S-nitrosothiols into the cytosol by cell-surface protein disulfide isomerase. Proc Natl Acad Sci U S A (2001) 1.51
NO forms an adduct with serum albumin that has endothelium-derived relaxing factor-like properties. J Clin Invest (1993) 1.44
Copper dependence of the biotin switch assay: modified assay for measuring cellular and blood nitrosated proteins. Free Radic Biol Med (2008) 1.43
Evidence for in vivo transport of bioactive nitric oxide in human plasma. J Clin Invest (2002) 1.42
Acute physical exercise reverses S-nitrosation of the insulin receptor, insulin receptor substrate 1 and protein kinase B/Akt in diet-induced obese Wistar rats. J Physiol (2007) 1.38
Mitochondria, oxidative stress, and temporal lobe epilepsy. Epilepsy Res (2009) 1.37
Regulation of protein function and signaling by reversible cysteine S-nitrosylation. J Biol Chem (2013) 1.35
The long history of iron in the Universe and in health and disease. Biochim Biophys Acta (2011) 1.33
Inhibition of neointimal proliferation in rabbits after vascular injury by a single treatment with a protein adduct of nitric oxide. J Clin Invest (1995) 1.32
Nitric oxide promotes distant organ protection: evidence for an endocrine role of nitric oxide. Proc Natl Acad Sci U S A (2008) 1.31
A tale of two gases: NO and H2S, foes or friends for life? Redox Biol (2013) 1.30
Hydrogen sulfide: a gasotransmitter of clinical relevance. J Mol Med (Berl) (2012) 1.29
Neuronal nitric-oxide synthase localization mediated by a ternary complex with synapsin and CAPON. Proc Natl Acad Sci U S A (2002) 1.27
S-nitrosylation of tissue-type plasminogen activator confers vasodilatory and antiplatelet properties on the enzyme. Proc Natl Acad Sci U S A (1992) 1.26
Mining literature for a comprehensive pathway analysis: a case study for retrieval of homocysteine related genes for genetic and epigenetic studies. Lipids Health Dis (2006) 1.25
Redox modulation by S-nitrosylation contributes to protein misfolding, mitochondrial dynamics, and neuronal synaptic damage in neurodegenerative diseases. Cell Death Differ (2011) 1.25
Polynitrosylated proteins: characterization, bioactivity, and functional consequences. Proc Natl Acad Sci U S A (1996) 1.25
Human spermatozoa contain multiple targets for protein S-nitrosylation: an alternative mechanism of the modulation of sperm function by nitric oxide? Proteomics (2007) 1.21
Endothelial Cell Dysfunction and the Pathobiology of Atherosclerosis. Circ Res (2016) 1.20
Balancing reactivity against selectivity: the evolution of protein S-nitrosylation as an effector of cell signaling by nitric oxide. Cardiovasc Res (2007) 1.20
Redox regulation of antioxidants, autophagy, and the response to stress: implications for electrophile therapeutics. Free Radic Biol Med (2014) 1.18
S-nitrosylation at cysteine 498 of c-Src tyrosine kinase regulates nitric oxide-mediated cell invasion. J Biol Chem (2009) 1.17
Redox regulation of mitochondrial fission, protein misfolding, synaptic damage, and neuronal cell death: potential implications for Alzheimer's and Parkinson's diseases. Apoptosis (2010) 1.16
Rapid nitric oxide-mediated S-nitrosylation of estrogen receptor: regulation of estrogen-dependent gene transcription. Proc Natl Acad Sci U S A (2005) 1.14
Redox reactions induced by nitrosative stress mediate protein misfolding and mitochondrial dysfunction in neurodegenerative diseases. Mol Neurobiol (2010) 1.13
S-nitrosylation: integrator of cardiovascular performance and oxygen delivery. J Clin Invest (2013) 1.12
Glutathione peroxidase potentiates the inhibition of platelet function by S-nitrosothiols. J Clin Invest (1995) 1.11
Macrophages resistant to endogenously generated nitric oxide-mediated apoptosis are hypersensitive to exogenously added nitric oxide donors: dichotomous apoptotic response independent of caspase 3 and reversal by the mitogen-activated protein kinase kinase (MEK) inhibitor PD 098059. Proc Natl Acad Sci U S A (1998) 1.07
Emerging role of protein-protein transnitrosylation in cell signaling pathways. Antioxid Redox Signal (2012) 1.06
Novel application of S-nitrosoglutathione-Sepharose to identify proteins that are potential targets for S-nitrosoglutathione-induced mixed-disulphide formation. Biochem J (2000) 1.06
Regulation of MyD88-dependent signaling events by S nitrosylation retards toll-like receptor signal transduction and initiation of acute-phase immune responses. Mol Cell Biol (2007) 1.06
Structure mechanism insights and the role of nitric oxide donation guide the development of oxadiazole-2-oxides as therapeutic agents against schistosomiasis. J Med Chem (2009) 1.05
Role of a copper (I)-dependent enzyme in the anti-platelet action of S-nitrosoglutathione. Br J Pharmacol (1996) 1.05
Desulfovibrio gigas flavodiiron protein affords protection against nitrosative stress in vivo. J Bacteriol (2006) 1.05
Nitric oxide induces Zn2+ release from metallothionein by destroying zinc-sulphur clusters without concomitant formation of S-nitrosothiol. Biochem J (1999) 1.04
Ethanol metabolism and effects: nitric oxide and its interaction. Curr Clin Pharmacol (2007) 1.04
Nitric oxide suppression of human hematopoiesis in vitro. Contribution to inhibitory action of interferon-gamma and tumor necrosis factor-alpha. J Clin Invest (1995) 1.03
Role of S-nitrosylation in apoptosis resistance and carcinogenesis. Nitric Oxide (2008) 1.02
Nitric oxide signaling mediates stimulation of L-type Ca2+ current elicited by withdrawal of acetylcholine in cat atrial myocytes. J Gen Physiol (1998) 1.02
Vascular effects of the red blood cell storage lesion. Hematology Am Soc Hematol Educ Program (2011) 1.01
Deconstructing endothelial dysfunction: soluble guanylyl cyclase oxidation and the NO resistance syndrome. J Clin Invest (2006) 1.01
The hemocompatibility of a nitric oxide generating polymer that catalyzes S-nitrosothiol decomposition in an extracorporeal circulation model. Biomaterials (2011) 1.01
Posttranslational modifications in connexins and pannexins. J Membr Biol (2012) 1.00
Effect of processing and storage on red blood cell function in vivo. Semin Perinatol (2012) 1.00
Methodologies for the characterization, identification and quantification of S-nitrosylated proteins. Biochim Biophys Acta (2011) 0.99
Murine macrophages use oxygen- and nitric oxide-dependent mechanisms to synthesize S-nitroso-albumin and to kill extracellular trypanosomes. Infect Immun (1998) 0.99
Inaccuracies of nitric oxide measurement methods in biological media. Anal Chem (2013) 0.98
Chloroquine stimulates nitric oxide synthesis in murine, porcine, and human endothelial cells. J Clin Invest (1998) 0.98
Effects of nitrogen monoxide and carbon monoxide on molecular and cellular iron metabolism: mirror-image effector molecules that target iron. Biochem J (2003) 0.98
Nitric oxide and thiol reagent modulation of Ca2+-activated K+ (BKCa) channels in myocytes of the guinea-pig taenia caeci. J Physiol (2000) 0.97
Nitric oxide reversibly inhibits the epidermal growth factor receptor tyrosine kinase. Biochem J (1997) 0.96
Thioredoxin-related protein of 14 kDa is an efficient L-cystine reductase and S-denitrosylase. Proc Natl Acad Sci U S A (2014) 0.96
Influence of gut microbiota on subclinical inflammation and insulin resistance. Mediators Inflamm (2013) 0.95
Selective fluorescent labeling of S-nitrosothiols (S-FLOS): a novel method for studying S-nitrosation. Nitric Oxide (2008) 0.95
Exogenous nitric oxide induces protection during hemorrhagic shock. Resuscitation (2009) 0.95
Inhibition of sphincter of Oddi function by the nitric oxide carrier S-nitroso-N-acetylcysteine in rabbits and humans. J Clin Invest (1994) 0.94
Characterization of erythrocytic uptake and release and disposition pathways of nitrite, nitrate, methemoglobin, and iron-nitrosyl hemoglobin in the human circulation. Drug Metab Dispos (2010) 0.93
The iron-responsive element binding protein: a target for synaptic actions of nitric oxide. Proc Natl Acad Sci U S A (1994) 0.93
Regulation of mitochondrial processes by protein S-nitrosylation. Biochim Biophys Acta (2011) 0.93
Nitric oxide increases persistent sodium current in rat hippocampal neurons. J Physiol (1999) 0.93
Enhanced release of nitric oxide causes increased cytotoxicity of S-nitroso-N-acetyl-DL-penicillamine and sodium nitroprusside under hypoxic conditions. Biochem J (1996) 0.93
The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature (1980) 40.02
Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature (1987) 35.44
Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci U S A (1987) 14.22
Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc Natl Acad Sci U S A (1990) 10.40
Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates. J Pharmacol Exp Ther (1981) 6.71
Correlation between nitric oxide formation during degradation of organic nitrates and activation of guanylate cyclase. Eur J Pharmacol (1987) 5.13
Vasorelaxant properties of the endothelium-derived relaxing factor more closely resemble S-nitrosocysteine than nitric oxide. Nature (1990) 4.28
Selection and characterization of bovine aortic endothelial cells. In Vitro (1978) 4.09
Stimulation of guanylate cyclase by sodium nitroprusside, nitroglycerin and nitric oxide in various tissue preparations and comparison to the effects of sodium azide and hydroxylamine. J Cyclic Nucleotide Res (1977) 3.70
Control of coronary vascular tone by nitric oxide. Circ Res (1990) 3.64
Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein. Circ Res (1989) 2.97
EPR demonstration of iron-nitrosyl complex formation by cytotoxic activated macrophages. Proc Natl Acad Sci U S A (1990) 2.94
Nitric oxide: biosynthesis and biological significance. Trends Biochem Sci (1989) 2.51
Spontaneous liberation of nitric oxide cannot account for in vitro vascular relaxation by S-nitrosothiols. J Pharmacol Exp Ther (1990) 2.10
Prostacyclin inhibits mobilisation of fibrinogen-binding sites on human ADP- and thrombin-treated platelets. Nature (1980) 1.87
Mechanism for the several activities of the glutathione S-transferases. J Biol Chem (1976) 1.74
Inhibition of human platelet aggregation by S-nitrosothiols. Heme-dependent activation of soluble guanylate cyclase and stimulation of cyclic GMP accumulation. Mol Pharmacol (1983) 1.68
N-acetylcysteine potentiates platelet inhibition by endothelium-derived relaxing factor. Circ Res (1989) 1.58
N-Acetylcysteine potentiates inhibition of platelet aggregation by nitroglycerin. J Clin Invest (1985) 1.57
Flow stimulates endothelial cells to release a nitrovasodilator that is potentiated by reduced thiol. Am J Physiol (1990) 1.47
Hormone-induced biosynthesis of endothelium-derived relaxing factor/nitric oxide-like material in N1E-115 neuroblastoma cells requires calcium and calmodulin. Mol Pharmacol (1990) 1.41
The lumi-aggregometer: a new instrument for simultaneous measurement of secretion and aggregation by platelets. J Lab Clin Med (1977) 1.40
Metabolic cooperation between vascular endothelial cells and smooth muscle cells in co-culture: changes in low density lipoprotein metabolism. J Cell Biol (1985) 1.27
Cardiovascular effects of acute hypercholesterolemia in rabbits. Reversal with lovastatin treatment. J Clin Invest (1989) 1.24
Requirement for reduced, unliganded hemoprotein for the hemoglobin- and myoglobin-mediated biotransformation of glyceryl trinitrate. J Pharmacol Exp Ther (1986) 1.14
Reaction of acidified nitrite solutions with peptide derivatives: evidence for nitrosamine and thionitrite formation from 15N N.m.r. studies. J Chem Soc Perkin 1 (1975) 1.04
Inhibition by ADP of prostaglandin induced accumulation of cyclic AMP in intact human platelets. J Cyclic Nucleotide Res (1981) 1.03
Thiol-mediated catalysis of nitroglycerin degradation by serum proteins. Increase in metabolism was not accompanied by S-nitrosothiol production. Drug Metab Dispos (1990) 0.99
[Inhibition of platelet aggregation by dinitrosyl iron complexes with low molecular weight ligands]. Biokhimiia (1986) 0.98
The reaction between organic nitrates and sulfhydryl compounds. A possible model system for the activation of organic nitrates. Mol Pharmacol (1985) 0.97
Structural and kinetic comparison of recombinant human single- and two-chain tissue plasminogen activator. J Clin Invest (1988) 0.97
Inhibition of cathepsin B and papain by peptidyl alpha-keto esters, alpha-keto amides, alpha-diketones, and alpha-keto acids. Arch Biochem Biophys (1990) 0.94
Oxidation of the 2-hydroxyamino derivative of 2-amino-6-methyl-dipyrido[1,2-a: 3',2'-d] imidazole (Glu-P-1) to its 2-nitroso form, an ultimate form reacting with hemoglobin thiol groups. Biochem Biophys Res Commun (1988) 0.89
Porcine corticosteroid-binding globulin: binding properties and levels in stress-susceptible swine. J Anim Sci (1974) 0.88
A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature (1993) 8.29
Biochemistry of nitric oxide and its redox-activated forms. Science (1992) 7.72
Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood (1998) 7.70
Homocysteine and atherothrombosis. N Engl J Med (1998) 6.70
Endothelial nitric oxide synthase: molecular cloning and characterization of a distinct constitutive enzyme isoform. Proc Natl Acad Sci U S A (1992) 4.32
Acylation targets emdothelial nitric-oxide synthase to plasmalemmal caveolae. J Biol Chem (1996) 3.75
Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin. Proc Natl Acad Sci U S A (1992) 3.72
Regulation of integrin function by the urokinase receptor. Science (1996) 3.56
Resolution of spontaneous bleeding events but failure of pregnancy in fibrinogen-deficient mice. Genes Dev (1995) 3.27
Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells. J Clin Invest (1998) 3.17
The biology of nitrogen oxides in the airways. Am J Respir Crit Care Med (1994) 2.90
Endothelial nitric oxide synthase targeting to caveolae. Specific interactions with caveolin isoforms in cardiac myocytes and endothelial cells. J Biol Chem (1996) 2.82
Reciprocal regulation of endothelial nitric-oxide synthase by Ca2+-calmodulin and caveolin. J Biol Chem (1997) 2.76
Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans. J Clin Invest (1990) 2.69
Endogenous nitrogen oxides and bronchodilator S-nitrosothiols in human airways. Proc Natl Acad Sci U S A (1993) 2.64
The platelet function defect of cardiopulmonary bypass. Blood (1993) 2.63
Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. J Clin Invest (1993) 2.47
Control of cardiac muscle cell function by an endogenous nitric oxide signaling system. Proc Natl Acad Sci U S A (1993) 2.32
Aspirin. Circulation (2000) 2.26
A noninvasive method of predicting pulmonary-capillary wedge pressure. N Engl J Med (1992) 2.12
Results of graft patency by immediate angiography in minimally invasive coronary artery surgery. Ann Thorac Surg (1999) 2.11
Regulation of nitric oxide synthase activity in human immunodeficiency virus type 1 (HIV-1)-infected monocytes: implications for HIV-associated neurological disease. J Exp Med (1995) 2.11
Structure of pre-pro-von Willebrand factor and its expression in heterologous cells. Nature (1987) 2.04
The oxyhemoglobin reaction of nitric oxide. Proc Natl Acad Sci U S A (1999) 1.99
Caveolin versus calmodulin. Counterbalancing allosteric modulators of endothelial nitric oxide synthase. J Biol Chem (1997) 1.99
Endothelial dysfunction in a murine model of mild hyperhomocyst(e)inemia. J Clin Invest (2000) 1.94
The endothelial nitric-oxide synthase-caveolin regulatory cycle. J Biol Chem (1998) 1.91
In vivo tracking of platelets: circulating degranulated platelets rapidly lose surface P-selectin but continue to circulate and function. Proc Natl Acad Sci U S A (1996) 1.90
The antiplatelet effects of ticlopidine and clopidogrel. Ann Intern Med (1998) 1.88
Cellular adhesion molecules and atherogenesis. Am J Med (1999) 1.88
Flow activates an endothelial potassium channel to release an endogenous nitrovasodilator. J Clin Invest (1991) 1.82
Nitric oxide-dependent parasympathetic signaling is due to activation of constitutive endothelial (type III) nitric oxide synthase in cardiac myocytes. J Biol Chem (1995) 1.80
Molecular cloning and characterization of human endothelial nitric oxide synthase. FEBS Lett (1992) 1.79
Inflammation and thrombosis: the clot thickens. Circulation (2001) 1.79
Homocyst(e)ine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase. J Biol Chem (1997) 1.77
The oxidant stress of hyperhomocyst(e)inemia. J Clin Invest (1996) 1.76
Regulation of vascular endothelial growth factor in cardiac myocytes. Circ Res (1995) 1.75
Paradoxical embolism: clinical presentation, diagnostic strategies, and therapeutic options. Am Heart J (1986) 1.64
N-acetylcysteine potentiates platelet inhibition by endothelium-derived relaxing factor. Circ Res (1989) 1.58
N-Acetylcysteine potentiates inhibition of platelet aggregation by nitroglycerin. J Clin Invest (1985) 1.57
In vivo electrophysiologic studies in endothelial nitric oxide synthase (eNOS)-deficient mice. J Cardiovasc Electrophysiol (2001) 1.56
Regulation of tissue factor expression in human microvascular endothelial cells by nitric oxide. Circulation (2000) 1.56
Nitric oxide and the control of firefly flashing. Science (2001) 1.56
The antiplatelet effects of organic nitrates and related nitroso compounds in vitro and in vivo and their relevance to cardiovascular disorders. J Am Coll Cardiol (1991) 1.55
Depalmitoylation of endothelial nitric-oxide synthase by acyl-protein thioesterase 1 is potentiated by Ca(2+)-calmodulin. J Biol Chem (1999) 1.55
Abnormal contractile function due to induction of nitric oxide synthesis in rat cardiac myocytes follows exposure to activated macrophage-conditioned medium. J Clin Invest (1993) 1.54
Peroxynitrite-induced rat colitis--a new model of colonic inflammation. Gastroenterology (1993) 1.53
In vivo transfer of nitric oxide between a plasma protein-bound reservoir and low molecular weight thiols. J Clin Invest (1994) 1.53
Heparin causes platelet dysfunction and induces fibrinolysis before cardiopulmonary bypass. Ann Thorac Surg (1995) 1.51
Sphingosine 1-phosphate and activation of endothelial nitric-oxide synthase. differential regulation of Akt and MAP kinase pathways by EDG and bradykinin receptors in vascular endothelial cells. J Biol Chem (2001) 1.50
Cell-surface protein disulfide isomerase catalyzes transnitrosation and regulates intracellular transfer of nitric oxide. J Clin Invest (1999) 1.49
Endothelial nitric oxide synthase. N-terminal myristoylation determines subcellular localization. J Biol Chem (1993) 1.49
Flow stimulates endothelial cells to release a nitrovasodilator that is potentiated by reduced thiol. Am J Physiol (1990) 1.47
A mAb to the beta2-leukocyte integrin Mac-1 (CD11b/CD18) reduces intimal thickening after angioplasty or stent implantation in rabbits. Proc Natl Acad Sci U S A (1998) 1.46
Pediatric death and fluoride-containing wheel cleaner. Ann Emerg Med (1998) 1.46
NO forms an adduct with serum albumin that has endothelium-derived relaxing factor-like properties. J Clin Invest (1993) 1.44
Homocysteine, oxidative stress, and vascular disease. Hosp Pract (1995) (1997) 1.44
Agonist-modulated palmitoylation of endothelial nitric oxide synthase. J Biol Chem (1995) 1.43
Deficient platelet-derived nitric oxide and enhanced hemostasis in mice lacking the NOSIII gene. Circ Res (1999) 1.41
Effects of race and hypertension on flow-mediated and nitroglycerin-mediated dilation of the brachial artery. Hypertension (2001) 1.38
Brain-derived neurotrophic factor and neurotrophin 3 in schizophrenic psychoses. Schizophr Res (2001) 1.37
Relaxation of human bronchial smooth muscle by S-nitrosothiols in vitro. J Pharmacol Exp Ther (1994) 1.36
Endothelial dysfunction in pulmonary hypertension. N Engl J Med (1992) 1.36
Estradiol induces the calcium-dependent translocation of endothelial nitric oxide synthase. Proc Natl Acad Sci U S A (1999) 1.35
Nitric oxide synthesis in endothelial cells: evidence for a pathway inducible by TNF-alpha. Am J Physiol (1991) 1.35
Bradykinin-regulated interactions of the mitogen-activated protein kinase pathway with the endothelial nitric-oxide synthase. J Biol Chem (2000) 1.35
Functional coupling of oxygen binding and vasoactivity in S-nitrosohemoglobin. J Biol Chem (2000) 1.34
Overexpression of cellular glutathione peroxidase rescues homocyst(e)ine-induced endothelial dysfunction. Proc Natl Acad Sci U S A (2001) 1.34
Dynamic targeting of the agonist-stimulated m2 muscarinic acetylcholine receptor to caveolae in cardiac myocytes. J Biol Chem (1997) 1.33
Inhibition of neointimal proliferation in rabbits after vascular injury by a single treatment with a protein adduct of nitric oxide. J Clin Invest (1995) 1.32
Familial dilated cardiomyopathy locus maps to chromosome 2q31. Circulation (1999) 1.32
Receptor-regulated translocation of endothelial nitric-oxide synthase. J Biol Chem (1998) 1.31
Expression of endothelial nitric oxide synthase in human and rabbit gastrointestinal smooth muscle cells. Am J Physiol (1998) 1.30
Decreased platelet inhibition by nitric oxide in two brothers with a history of arterial thrombosis. J Clin Invest (1996) 1.29
Antiplatelet properties of protein S-nitrosothiols derived from nitric oxide and endothelium-derived relaxing factor. Arterioscler Thromb (1993) 1.28
Inhibition of fibrinogen binding to human platelets by S-nitroso-N-acetylcysteine. J Biol Chem (1990) 1.28
Nitric oxide released from activated platelets inhibits platelet recruitment. J Clin Invest (1997) 1.28
Agonist-modulated targeting of the EDG-1 receptor to plasmalemmal caveolae. eNOS activation by sphingosine 1-phosphate and the role of caveolin-1 in sphingolipid signal transduction. J Biol Chem (2000) 1.27
Simplified risk score models accurately predict the risk of major in-hospital complications following percutaneous coronary intervention. Am J Cardiol (2001) 1.27
S-nitrosylation of tissue-type plasminogen activator confers vasodilatory and antiplatelet properties on the enzyme. Proc Natl Acad Sci U S A (1992) 1.26
Culture and decontamination methods affecting enumeration of phages infecting Bacteroides fragilis in sewage. Appl Environ Microbiol (1992) 1.26
Polynitrosylated proteins: characterization, bioactivity, and functional consequences. Proc Natl Acad Sci U S A (1996) 1.25
Sphingosine 1-phosphate and isoform-specific activation of phosphoinositide 3-kinase beta. Evidence for divergence and convergence of receptor-regulated endothelial nitric-oxide synthase signaling pathways. J Biol Chem (2001) 1.25